NASDAQ: AXGNAxogen Inc Stock Ownership - Who owns Axogen?
Insider buying vs selling
Have Axogen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Erick Wayne Devinney | Chief Innovation Officer | 2026-03-16 | 5,221 | $32.84 | $171.46kSell |
| Lindsey Marie Hartley | CFO | 2026-03-16 | 1,968 | $32.84 | $64.63kSell |
| Lindsey Marie Hartley | CFO | 2026-03-16 | 1,574 | $32.84 | $51.69kSell |
| Erick Wayne Devinney | Chief Innovation Officer | 2026-03-16 | 2,870 | $32.84 | $94.25kSell |
| Erick Wayne Devinney | Chief Innovation Officer | 2026-03-01 | 11,276 | $30.65 | $345.61kSell |
| Jens Kemp | Chief Marketing Officer | 2026-03-01 | 2,952 | $30.65 | $90.48kSell |
| Marc A. Began | EVP General Counsel | 2026-03-01 | 4,427 | $30.65 | $135.69kSell |
| Lindsey Marie Hartley | CFO | 2026-02-26 | 6,630 | $31.90 | $211.50kSell |
| Jens Kemp | Chief Marketing Officer | 2026-02-26 | 15,414 | $31.90 | $491.71kSell |
| Marc A. Began | EVP General Counsel | 2026-02-26 | 8,753 | $31.90 | $279.22kSell |
AXGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AXGN insiders and whales buy or sell their stock.
AXGN Shareholders
What type of owners hold Axogen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Guido J. Neels | 16.03% | 8,318,965 | $276.86M | Insider |
| First Light Asset Management LLC | 10.08% | 5,233,326 | $174.17M | Institution |
| Joseph M. Mandato | 7.86% | 4,079,557 | $135.77M | Insider |
| Blackrock Inc | 7.17% | 3,719,437 | $123.78M | Institution |
| Ew Healthcare Partners LP | 7.15% | 3,711,111 | $123.51M | Insider |
| James E. Flynn | 5.78% | 3,000,000 | $99.84M | Insider |
| Vanguard Group Inc | 5.53% | 2,869,955 | $95.51M | Institution |
| De Novo Ventures II LP | 5.50% | 2,852,784 | $94.94M | Insider |
| Morgan Stanley | 4.98% | 2,586,870 | $86.09M | Institution |
| Arrowmark Colorado Holdings LLC | 2.84% | 1,474,282 | $49.06M | Institution |
AXGN vs Medical Device Stocks
Axogen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.